HomeCompareGEOVF vs O

GEOVF vs O: Dividend Comparison 2026

GEOVF yields 27.24% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GEOVF wins by $78.5K in total portfolio value
10 years
GEOVF
GEOVF
● Live price
27.24%
Share price
$7.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112.7K
Annual income
$13,705.74
Full GEOVF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — GEOVF vs O

📍 GEOVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGEOVFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GEOVF + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GEOVF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GEOVF
Annual income on $10K today (after 15% tax)
$2,315.00/yr
After 10yr DRIP, annual income (after tax)
$11,649.88/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, GEOVF beats the other by $7,312.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GEOVF + O for your $10,000?

GEOVF: 50%O: 50%
100% O50/50100% GEOVF
Portfolio after 10yr
$73.5K
Annual income
$9,404.24/yr
Blended yield
12.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

GEOVF
Analyst Ratings
1
Buy
Consensus: Buy
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GEOVF buys
0
O buys
0
No recent congressional trades found for GEOVF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGEOVFO
Forward yield27.24%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$112.7K$34.2K
Annual income after 10y$13,705.74$5,102.74
Total dividends collected$74.0K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: GEOVF vs O ($10,000, DRIP)

YearGEOVF PortfolioGEOVF Income/yrO PortfolioO Income/yrGap
1← crossover$13,424$2,723.53$10,818$608.16+$2.6KGEOVF
2$17,780$3,416.77$11,787$741.68+$6.0KGEOVF
3$23,254$4,229.57$12,946$911.00+$10.3KGEOVF
4$30,052$5,169.89$14,345$1,127.94+$15.7KGEOVF
5$38,399$6,244.07$16,056$1,409.05+$22.3KGEOVF
6$48,544$7,456.58$18,171$1,777.83+$30.4KGEOVF
7$60,752$8,809.80$20,820$2,268.21+$39.9KGEOVF
8$75,309$10,304.01$24,188$2,929.90+$51.1KGEOVF
9$92,517$11,937.32$28,533$3,837.11+$64.0KGEOVF
10$112,699$13,705.74$34,235$5,102.74+$78.5KGEOVF

GEOVF vs O: Complete Analysis 2026

GEOVFStock

Genovis AB (publ.) designs, develops, and sells tools for development of drugs for customers in the pharmaceutical and medical device industries. The company offers FabALACTICA, a cysteine protease that digests human IgG1; FabRICATOR, an enzyme that primarily digests the hinge region of IgG; and FabRICATOR Z, an enzyme for the digestion of mouse IgG2a and IgG3, as well as for generating a homogenous pool of F(ab')2 and Fc fragments. It also provides FabULOUS (SpeB), an enzyme for the digestion of IgG in the hinge region; and GingisKHAN, a cysteine protease that digests human IgG1 at a specific site above the hinge. In addition, the company offers GingisREX, a cysteine protease that specifically digests peptide bonds C-terminally to arginine residues; and IgGZERO (EndoS), an endoglycosidase from Streptococcus pyogenes that specifically hydrolyzes N-linked glycans in the Fc-region of native IgG. Further, it provides IgGZERO LE, an endoglycosidase acting on complex type N-glycans from Streptococcus pyogenes; deGlycIT, an IgGZERO (EndoS) enzyme for agarose beads for deglycosylation of Fc-glycans; GlycINATOR an endoglycosidase from Streptococcus pyogenes that hydrolyzes the all glycoforms structure; and GlycINATOR (EndoS2), an endoglycosidase from Streptococcus pyogenes that specifically hydrolyzes glycans at the Fc glycosylation site of IgG. Additionally, the company offers GlyCLICK, a site-specific conjugation technology used for IgG on enzymatic remodeling of the Fc glycans and click chemistry; SialEXO, a sialidase product for the removal and analysis of sialic acids; enzymes for O-glycans; and antibody fragmentation services, as well as operates online store for its products. It serves pharmaceutical and biotech, contract research, and contract manufacturing companies in Sweden, Europe, North America, and Asia. The company has a collaboration with Waters Corporation. Genovis AB (publ.) was founded in 1999 and is based in Lund, Sweden.

Full GEOVF Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this GEOVF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GEOVF vs SCHDGEOVF vs JEPIGEOVF vs KOGEOVF vs MAINGEOVF vs STAGGEOVF vs ADCGEOVF vs NNNGEOVF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.